The Republican Center for Research and Practice in Otolaryngology, Belarus Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2017
NCT03130374
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

The Republican Center for Research and Practice in Otolaryngology | The Republican Research and Practical Center for Epidemiology and Microbiology, Minsk, Belarus

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Constriction, Pathologic (Phase 2)

Laryngostenosis (Phase 2)

Pancreatic Neoplasms (Phase 2)

Tracheal Stenosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 3